Caffeine in the modulation of brain function

Caffeine and Behavior: Current Views & Research Trends: Current Views and Research Trends

Volumn , Issue , 2020, Pages 17-30

  Myers, J Patrick ^a   Johnson, David A ^b   McVey, Devon E ^c  

^a Department of Psychology and Social Sciences at Mount Aloysius College in Cresson   (United States)

^b DUQUESNE UNIVERSITY   (United States)

^c A Subsidiary of Neurolign Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85108768901     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780429271038-2     Document Type: Chapter

References (79)

1. Bianchi, C. P., The effect of caffeine on radiocalcium movement in frog sarto-rius, J. Gen. Physiol, 44, 845, 1961.
2. Guthrie, J. R. and Nayler, W. G, Interaction between caffeine and adenosine on calcium exchangeability in mammalian atria. Arch. Intern. Pharmacodyn. Ther., 170, 323, 1967.
3. Bianchi, C. P., Cellular pharmacology of contraction of skeletal muscle, in Cellular Pharmacology of Excitable Tissues, Narahashi, T., Ed., Charles C. Thomas, Springfield, 1975, 485.
4. Hughes, A. D., Herring, S., and Bolton, T. B., The action of caffeine on inward barium current through voltage dependent calcium channels in single rabbit ear artery cells, Pfluegers Arch., 416, 462, 1990.
5. Mironov, S. L. and Usachev, J. M., Caffeine affects Ca+ uptake and Ca+ release from intracellular stores: fura-2 measurements in isolated snail neurons, Neurosci Lett, 123, 200, 1991.
6. Sandow, A. and Brust, M., Caffeine potentiation of twitch tension of sartorius muscle, Biochemistry, 345, 232, 1996.
7. Rail, T. W., Central nervous system stimulants: the xanthines, in The Pharmacological Basis of Therapeutics, 6th ed., Goodman, L. S. and Gilman, A., Eds., MacMillan, New York, 1980, 592.
8. Fredholm, B. B., On the mechanism of action of theophylline and caffeine, Acta Med. Scand., 217, 149, 1985.
9. Burg, A. W. and Warner, E., Effect of orally administered caffeine and theophylline on tissue concentrations of 3', 5'-cyclic AMP and phosphodiesterase (Abstract), Fed. Proc, 34, 332, 1975.
10. Wachtel, H., Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'- monophosphate phosphodiesterase inhibitors, Psychopharmacology, 77, 309, 1982.
11. Sattin, A. and Rail T. W, The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5' phosphates content of guinea pig cerebral cortex slices, Mol Pharmacol, 6, 13, 1970.
12. Pedata, G., Pepeu, G, and Spignoli, G, Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices, Br. J. Pharmacol, 83, 69, 1984.
13. Rail, T. W, Drugs used in the treatment of asthma, in, Goodman and Gilman s The Pharmacological Basis of Therapeutics, 8th ed., Gilman, A., Rail, T. W, Nies, A. S., and Taylor, P., Eds., Pergamon Press, New York, 1990, 618.
14. File, S. E., Bond, A. J., and Lister, R. G., Interaction between effects of caffeine and lorazepam in performance tests and self-ratings, J. Clin. Psychopharmacol, 2, 102, 1982.
15. Weir, R. L. and Hruska, R. E., Interaction between methylxanthines and the benzodiazepine receptor, Arch. Intern. Pharmacodyn. Ther., 265, 42, 1983.
16. Williams, M., Purine receptors in mammalian tissues: pharmacology and functional significance, Annu. Rev. Pharmacol. Toxicol, 27, 315, 1987.
17. Daval, J. L., Deckert, J., Weiss, S. R. B., Post, R. M., and Marangos, P. J., Up-regulation of adenosine Al receptors and forskolin binding sites following chronic caffeine treatment with caffeine of carbamazepine: a quantitative autoradiographic study, Epilepsia, 30, 26, 1989.
18. Fastbom, J. and Fredholm, B. B., Effects of long-term theophylline treatment on adenosine Arreceptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins, Brain Res., 507, 195, 1990.
19. Lupica, C. R., Jarvis, M. R, and Berman, R. R, Chronic theophylline treatment in vivo increases high affinity adenosine A, receptor binding and sensitivity to exogenous adenosine in the in vitro hippocampal slice, Brain Res., 542, 55, 1991.
20. Matthew, R. J. and Wilson, W. H., Caffeine induced changes in cerebral circulation, Stroke, 16, 814, 1985.
21. Karasawa, T., Furukawa, K., Yoshida, K., and Shimizu, M., Effect of theophylline on monoamine metabolism in the rat brain, Eur.J. Pharmacol, 37, 97, 1976.
22. Schlosberg, A. J., Fernstrom, J. Dv Kopczynski, M. C, Cusack, B. M., and Gillis, M. A., Acute effects of caffeine injection on neutral amino acids and brain monoamine level in rats, Life Sci., 29, 173, 1981.
23. Chou, D. T., Cuzzone, H., Springstead, J., Ali, R., and Hirsh, K., Differential effects of caffeine on regional brain biogenic amines in rats, Soc. Neurosci. Abstr., 5, 551, 1979.
24. Costill, D. L., Dalsky, G., and Fink, W., Effects of caffeine ingestion on metabolism and exercise performance, Med.Sci. Sports Exer., 10, 155, 1978.
25. Atkinson, J. and Enslen, M., Self-administration of caffeine by the rat, Arzne-imittelforsch, 26, 2059, 1976.
26. Grant, S. J. and Redmond, Jr., D. E., Methylxanthine activation of noradrenergic unit activity and reversal by clonidine, Eur. J. Pharmacol, 85, 105, 1982.
27. Fernstrom, M. H., Bazil, C. W., and Fernstrom, J. D., Caffeine injection raises brain tryptophan level, but does not stimulate the rate of serotonin synthesis in rat brain, Life Sci., 35, 1241, 1984.
28. Fredholm, B. B., Jonzon, B., and Lendgren, E., Changes in noradrenaline release and in beta receptor number in rat hippocampus following long term treatment with theophylline or L-PIA, Acta Physiol Scand., 122, 55, 1984.
29. Stern, K. N., Chait, L. D., and Johanson, C. E., Reinforcing and subjective effects of caffeine in norma human volunteers, Psychopharmacology, 98, 81, 1989.
30. Berkowitz, B. A., Tarver, J. H., and Spector, S., Release of norepinephrine in the central nervous system by theophylline and caffeine, Eur. J. Pharmacol, 10, 64, 1970.
31. Eitan, A. and Hershkowitz, M., The effects of dibutyril cyclic AMP, theophylline and papaverine on the release of 3H-catecholamines from rat brain striatal and cortical synaptosomes, Eur.J. Pharmacol, 46, 323, 1977.
32. Cardinali, D. P., Effects of pentoxiphylline and theophylline on biogenic amine metabolism in the rat brain, Eur. J. Pharmacol, 47, 239, 1978.
33. Michaelis, M. L., Michaelis, E. K., and Myers, S. L., Adenosine modulation of synaptosomal dopamine release, Life Sci., 24, 2083, 1979.
34. Goldberg, M. R., Curatolo, P. W., and Robertson, D., Caffeine down regulates B- receptors in rat forebrain, Neurosci. Lett., 31, 47, 1982.
35. Galloway, M. P. and Roth, R. H., Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain, J. Neurochem., 40, 246, 1983.
36. Atuk, N. O., Blaydes, M. C, Westervelt, Jr., F. B., and Wood, J. E., Jr., Effect of aminophylline on urinary excretion of epinephrine and norepinephrine in man, Circulation, 35, 745, 1967.
37. Govoni, S., Petkov, V. V., and Montefusco, O., Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures, J. Pharm. Pharmacol, 36, 458, 1984.
38. White, B. C. and Keller III, G. E., Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity, Pharmacol Biochem. Behav., 20, 383, 1984.
39. Misra, A. L., Vadlamani, N. L., and Pontani, R. B., Effect of caffeine on cocaine locomotor stimulant activity in rats, Pharmacol. Biochem. Behav., 24, 761, 1986.
40. Klawans, H. L., Moses III, H., and Beaulieu, D. M., The influence of caffeine on amphetamine-induced activity, Life Sci., 14, 1493, 1974.
41. Yokogoshi, H., Tani, S., and Amano, N., The effects of caffeine and caffeine-containing beverages on the disposition of brain serotonin in rats, Agric, Biol, Chem., 51, 3281, 1987.
42. Haleem, D. J., Yasmeen, A., Haleem, M. A., and Zafar, A., 24-Hour withdrawal following repeated administration of caffeine attenuates brain serotonin but not tryptophan in rat brain: implications for caffeine-induced depression, Life Sci, 57, PL285, 1995.
43. Fernstrom, J. D. and Fernstrom, M. H., Effects of caffeine on monoamine neurotransmitters in the central and peripheral nervous system, in Caffeine: Perspectives from Recent Research, Dews, P. B., Ed., Springer, Heidelberg, 1984, 107.
44. Yokogoshi, H., Phenylalanine inhibits caffeine-induced increase in brain serotonin concentrations in rats, Agric. Biol Chem., 52, 3173, 1988.
45. Berkowitz, B. A. and Spector, S., The effect of caffeine and theophylline on the disposition of brain serotonin in the rat, Eur.J. Pharmacol, 16, 322, 1971.
46. Stromberg, U. and Waldeck, B., Behavioural and biochemical interaction between caffeine and L-DOPA, J. Pharm. Pharmacol, 25, 302, 1973.
47. Hirsh, K., Central nervous system pharmacology of the dietary methylxanthines, in The Methylxanthines Beverages and Foods: Chemistry, Consumption, and Health Effects, Spiller, G. A. and Alan, R., Eds., Alan R. Liss, New York, 1984, 235.
48. Jouvet, M., Biogenic amines and the states of sleep, Science, 163, 32, 1969.
49. Gumulka, W., Samanin, R., Valzelli, L., and Console, S., Behavioral and biochemical effects following the stimulation of the nucleus raphe dorsalis in rats, J. Neurochem., 18, 533, 1971.
50. Holman, R. B., Glen, R., Elliot, B. S., and Barchas, J. D., Neuroregulators and sleep mechanisms, Annu. Rev. Med., 26, 499, 1975.
51. Warbritton, J. D., Stewart, R. M., and Baldessarini, R. J., Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine, Brain Res., 177, 355, 1980.
52. Murray, T. R, Blaker, W. D., Cheney, D. L, and Costa, E., Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs, J. Pharmacol Exp. Therap., 222, 550, 1982.
53. Pedata, R, Pepeu, G, and Spignoli, G., Effects of methylxanthines on acetylcholine release from electrically stimulated cortical slices (Abstract), Br. J. Pharmacol, 80 Suppl., 471P, 1983.
54. Corradetti, R., Pedata, R, Pepeu, G, and Vannucchi, M. G, Chronic caffeine treatment reduces caffeine but not adenosine effects on cortical acetylcholine release, Br. J. Pharmacol, 88, 671, 1986.
55. Reith, M. E. A., Sershen, H., and Lajtha, A., Effects of caffeine on monoamin-ergic systems in mouse brain, Acta Biochim. Biophysich. Hungaria, 22, 149, 1987.
56. Hadfield, M. G. and Milio, C, Caffeine and regional brain monoamine utilization in mice. Life Sci., 45, 2637, 1989.
57. Kirch, D. G., Taylor, T. R., Gerhardt, G. A., Benowitz, N. L., Stephen, C, and Wyatt, R. J., Effect of chronic caffeine administration of monoamine and monoamine metabolite concentrations in the rat brain, Neuropharmacology, 29, 599, 1980.
58. Phillis, J. W., Siemens, R. K., and Wu, P. H., Effects of diazepam on adenosine and acetylcholine release from rat cerebral cortex: further evidence for a pu-rinergic mechanism in the action of diazepam, Br. J. Pharmacol, 70, 1085, 1980.
59. Johnson, D. A., Ulus, I. H., and Wurtman, R. J., Caffeine potentiates the enhancement of striatal acetylcholine release, Life Sci., 51, 1597, 1992.
60. Carter, A. J., O’Connor, W. T., Carter, M. J., and Ungerstedt, U., Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with Adenosine Al receptors, J. Pharmacol Exp. Therap., 273, 637, 1995.
61. Shi, D., Nikodijevic, O., Jacobson, K. A., and Daly, J. W., Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice, Arch. Internation. Pharmacol Ther., 328, 261, 1994.
62. Lajtha, I. J., Banay-Schwartz, M., and Lajtha, A., The effect of caffeine on some mouse brain free amino acid levels, Nenrochem. Res., 14, 317, 1989.
63. Portoles, M., Minana, M. D., Jorda, A., and Grisolia, S., Caffeine-induced changes in the composition of the free amino acid pool of the cerebral cortex, Neurochem. Res., 10, 887, 1985.
64. Colombatto, S., Fasulo, L., Mondardini, A., Malabaila, A., and Grillo, M. A., Effect of caffeine of ornithine metabolism in rat brain, liver and kidney, Ital. J. Biochem., 28, 75, 1989.
65. Marangos, P. J., Paul, S. M, and Goodwin, F. K., Putative endogenous ligands for the benzodiazepine receptor, Life Sci., 25, 1093, 1979.
66. Wu, P. H. and Coffin, V. L., Up-regulation of brain PH]diazepam binding sites in chronic caffeine-treated rats, Brain Res., 294, 186, 1984.
67. Boulenger, J. P., Salem, N., Marangos, P. J., and Uhde, T. W, Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine, Psychiat. Res., 21, 247, 1987.
68. Daval, J. L. and Vert, P., Effect of chronic caffeine exposure to methylxanthines on Diazepam cerebral binding in female rats and their offspring, Develop. Brain Res., 27, 175, 1986.
69. Hunter, R. E., Barrera, C. M., Dohanich, G. P., and Dunlap, W. P., Effects of uric acid and caffeine of Al adenosine receptor binding in developing rat brain, Pharmacol Biochem. Behav., 35, 791, 1990.
70. Koe, B. K., Kondratas, E., and Russo, L. L., PH]Rol5-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs, Eur. J. Pharmacol, 142, 373, 1987.
71. Wu, P. H. and Phillis, J.W, Up-regulation of brain PH] diazepam binding sites in chronic caffeine treated rats, Gen. Pharmacol, 17, 501, 1988.
72. Kaplan, G. B., Greenblatt, D. J., Leduc, B. W, Thompson, M. L., and Shader, R. I., Relationship of plasma and brain concentration of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity, J. Pharmacol Exp. Therap., 248, 1078, 1989.
73. Boulenger, J. P., Marangos, P. J., Zander, K. J., and Hanson, J., Stress and caffeine: effects on central adenosine receptors, Clin. Neuropharmacol, 9, 79, 1986.
74. Lopez, R, Miller, L. G., Greenblatt, D. J., Kaplan, G. B., and Shader, R. L, Interaction of caffeine with the GABAA complex: alterations in receptor function but not ligand binding, Eur. J. Pharmacol, 172, 453, 1989.
75. Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. R, and Daly, J. W, Adenosine receptors and behavioral actions of methylxanthines, Proc. Natl Acad. Sci. U.S.A, 78, 3260, 1981.
76. Nehlig, A., Daval, J. L., Pereira De Vasconcelos, A., and Boyet, S., Caffeine-diazepam interaction and local glucose utilization in the conscious rat, Brain Res., 419, 272, 1987.
77. Pole, P., Bonetti, E. P., Pieri, L., Cumin, R., Angioi, R. M., Mohler, H., and Haefely, W. E., Caffeine antagonizes several central effects of Diazepam, Life Sci., 28, 2265, 1981.
78. Nehlig, A., Daval, J. L., and Debry, G., Caffeine and the central nervous system: Mechanism of action, biochemical, metabolic, and psychostimulant effects, Brain Res. Rev., 17, 139, 1992.
79. Gupta, U., Effects of caffeine on recognition, Pharmacol. Biochem. Behav., 44, 393, 1993.